CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

NCT07432178 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

2288

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Dalpiciclib+AI ± OFS
DRUG: TC (Docetaxel + Cyclophosphamide) × 4 cycles- endocrine therapy

Sponsor

Fudan University